Saturday 16 Oct, 2021 10:35 PM
Site map | Locate Us | Login
   HDFC Bank hits record high ahead of Q2 earnings    ITC jumps 11% in four days amid buzz of likely tieup with Amazon    Arvind Ltd leads losers in 'A' group    Arshiya Ltd leads losers in 'B' group    GTPL Hathway slips after Q2 PAT drops nearly 5% YoY    Volumes jump at Lakshmi Machine Works Ltd counter    Telecom shares fall    Auto stocks edge lower    Century Textiles soars after turnaround in Q2 performance     Escorts appoints Sanjeev Bajaj as head of construction equipment biz    Jindal Steel & Power Ltd up for third straight session    Adani Enterprises Ltd in demand    Mphasis Ltd sees sustained buying    Wipro Ltd spurts 7.44%, gains for third straight session    Vedanta Ltd stays supported 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Shilpa Medicare ties up with Cadila Healthcare for production of ZyCoV-D vaccine
24-Sep-21   14:21 Hrs IST

Cadila Healthcare will transfer the ZyCoV-D technology to Shilpa Biologicals, wholly owned subsidiary of Shilpa Medicare. Under the agreement, Shilpa Biologicals will be responsible for manufacture of the drug substance of the vaccine, while Cadila Healthcare will be responsible for filling, packaging, distribution and marketing of the vaccine in its territories.

The targeted production of the ZyCoV-D vaccine from the facility will be mutually agreed upon by Cadila Healthcare and Shilpa Medicare. ZyCov-D is the first DNA plasmid vaccine in the world for human use developed indigenously by CHL against the Covid-19 virus. It is also the first COVID-19 vaccine for adolescents in the 12-18 age group, besides the adult population.

The drug company's biologics business has been identified as a strategic growth engine and it has made significant investments in setting up a high end, flexible biologics facility in SBPL. The facility at Dharwad would cater to the requirements of the fast-growing biologics field, that include the DNA vaccine, adenoviral, subunit vaccines, monoclonal antibodies & fusion proteins.

Shares of Shilpa Medicare were trading 0.49% lower at Rs 569.30 while Cadila Healthcare was down 0.34% at Rs 565 on BSE.

Shilpa Medicare is a global brand in manufacturing and supplying of affordable API and formulation globally in different regulated markets. Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 18026987
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd